Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.

Molecular diagnosis & therapy - 1 Feb 2011

Xu Sihong, Zhong Ping, Li Jingyun, Song Aijing, Li Hanping, Nie Jianhui, Li Xiuhua, Wang Youchun

Abstract excerpt

BACKGROUND AND OBJECTIVE: With the introduction of the ViroSeq™ HIV-1 Genotyping System (ViroSeq™ assay) into China, it is important to evaluate the impact of the diversity of HIV-1 genotypes found in China on the performance of the ViroSeq™ assay compared with an in-house method. MATERIALS AND METHODS: A total of 318 plasma samples, collected from 206 HIV-1-infected patients receiving antiretroviral therapy and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to China
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to HIV Infections

Share to Mutation

Share to Protease Inhibitors

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 21469769
DOI: 10.1007/BF03257192

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.PMID 21469769Read ↗

Comparison between an in-house method and the ViroSeq™ method for determining mutations for drug resistance in the HIV-1 CRF01_AE subtype circulating in China.Semantic proximity Read ↗

Evaluation of a Novel In-house HIV-1 Genotype Drug Resistance Assay using Clinical Samples in China.Semantic proximity Read ↗

Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq™ 2.0 genotyping system as a gold standard.Semantic proximity Read ↗

[The study of an in-house method for drug resistance genotyping testing on HIV-1 strains prevailing in China].Semantic proximity Read ↗

Retrospective analysis of HIV-1 drug resistance mutations in Suzhou, China from 2009 to 2014.Semantic proximity Read ↗

Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, ChinaSemantic proximity Read ↗

Clinical evaluation of an in-house human immunodeficiency virus (HIV) genotyping assay for the detection of drug resistance mutations in HIV-1 infected patients in Singapore.Semantic proximity Read ↗

Drug resistance mutation profiles of the drug-naïve and first-line regimen-treated HIV-1-infected population of Suzhou, China.Semantic proximity Read ↗

Development and evaluation of a national reference panel of HIV-1 protease and reverse transcriptase drug-resistance mutations for HIV-1 genotypic resistance assays in China.Semantic proximity Read ↗

Prevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing.Semantic proximity Read ↗

Characterization of HIV-1 subtypes and transmitted drug resistance among treatment-naive HIV-infected individuals in Zhejiang, China, 2014-2017.Semantic proximity Read ↗

HIV-1 molecular epidemiology and drug resistance-associated mutations among treatment-naïve blood donors in China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.